Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Rodnitzky

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neurology|December 28, 2013
Amantadine's role in the treatment of levodopa-induced dyskinesiaRobert L Rodnitzky, Nandakumar S Narayanan
Movement Disorders : Official Journal of the Movement Disorder Society|April 8, 2006
Isolated high-frequency jaw tremor relieved by botulinum toxin injectionsPedro Gonzalez-Alegre, Praful Kelkar, Robert L Rodnitzky
Parkinsonism & Related Disorders|August 20, 2011
Secondary dystonia in a botulinum toxin clinic: clinical characteristics, neuroanatomical substrate and comparison with idiopathic dystoniaScott Strader, Robert L Rodnitzky, Pedro Gonzalez-Alegre
Reviews in the Neurosciences|June 5, 2013
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's diseaseNandakumar S Narayanan, Robert L Rodnitzky, Ergun Y Uc
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2008
From essential tremor to Klinefelter through Fragile X, an unexpected journeyTanya L Harlow, Robert L Rodnitzky, Pedro Gonzalez-Alegre
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2003
Moyamoya-induced paroxysmal dyskinesiaPedro Gonzalez-Alegre, Zakaria Ammache, Patricia H Davis, et al.
Journal of the Neurological Sciences|June 18, 2003
The midlatency auditory evoked potential P50 is abnormal in Huntington's diseaseErgun Y Uc, Robert D Skinner, Robert L Rodnitzky, et al.
Parkinsonism & Related Disorders|June 1, 2002
Linking clinical variables to health-related quality of life in Parkinson's diseaseElizabeth A Chrischilles, Linda M Rubenstein, Margaret D Voelker, et al.
Clinical Neuropharmacology|August 5, 2003
Albuterol improves response to levodopa and increases skeletal muscle mass in patients with fluctuating Parkinson diseaseErgun Y Uc, Charles P Lambert, Sami I Harik, et al.
Annals of Neurology|September 14, 2006
Impaired visual search in drivers with Parkinson's diseaseErgun Y Uc, Matthew Rizzo, Steven W Anderson, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neurology|December 28, 2013
Amantadine's role in the treatment of levodopa-induced dyskinesiaRobert L Rodnitzky, Nandakumar S Narayanan
Movement Disorders : Official Journal of the Movement Disorder Society|April 8, 2006
Isolated high-frequency jaw tremor relieved by botulinum toxin injectionsPedro Gonzalez-Alegre, Praful Kelkar, Robert L Rodnitzky
Parkinsonism & Related Disorders|August 20, 2011
Secondary dystonia in a botulinum toxin clinic: clinical characteristics, neuroanatomical substrate and comparison with idiopathic dystoniaScott Strader, Robert L Rodnitzky, Pedro Gonzalez-Alegre
Reviews in the Neurosciences|June 5, 2013
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's diseaseNandakumar S Narayanan, Robert L Rodnitzky, Ergun Y Uc
Movement Disorders : Official Journal of the Movement Disorder Society|May 9, 2008
From essential tremor to Klinefelter through Fragile X, an unexpected journeyTanya L Harlow, Robert L Rodnitzky, Pedro Gonzalez-Alegre
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2003
Moyamoya-induced paroxysmal dyskinesiaPedro Gonzalez-Alegre, Zakaria Ammache, Patricia H Davis, et al.
Journal of the Neurological Sciences|June 18, 2003
The midlatency auditory evoked potential P50 is abnormal in Huntington's diseaseErgun Y Uc, Robert D Skinner, Robert L Rodnitzky, et al.
Parkinsonism & Related Disorders|June 1, 2002
Linking clinical variables to health-related quality of life in Parkinson's diseaseElizabeth A Chrischilles, Linda M Rubenstein, Margaret D Voelker, et al.
Clinical Neuropharmacology|August 5, 2003
Albuterol improves response to levodopa and increases skeletal muscle mass in patients with fluctuating Parkinson diseaseErgun Y Uc, Charles P Lambert, Sami I Harik, et al.
Annals of Neurology|September 14, 2006
Impaired visual search in drivers with Parkinson's diseaseErgun Y Uc, Matthew Rizzo, Steven W Anderson, et al.
Pageof 3